BioSyent Inc. announced that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 2024, to shareholders of record at the close of business on May 31, 2024. This second quarter 2024 dividend compares with the first quarter 2024 dividend of $0.045 per common share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 CAD | +0.55% | 0.00% | -1.30% |
05-17 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
05-17 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.30% | 78.21M | |
+42.64% | 739B | |
+32.34% | 598B | |
-5.73% | 353B | |
+17.33% | 318B | |
+3.44% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.09% | 164B |
- Stock Market
- Equities
- RX Stock
- News BioSyent Inc.
- BioSyent Inc Declares Second Quarter 2024 Dividend, Payable June 15, 2024